Cost utility analysis of early adjuvant letrozole or anastrozole versus tamoxifen in postmenopausal women with early invasive breast cancer: the UK perspective.
Karnon, Jonathan
Cost utility analysis of early adjuvant letrozole or anastrozole versus tamoxifen in postmenopausal women with early invasive breast cancer: the UK perspective. [electronic resource] - The European journal of health economics : HEPAC : health economics in prevention and care May 2008 - 171-83 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1618-7598
10.1007/s10198-007-0058-1 doi
Anastrozole
Antineoplastic Agents--administration & dosage
Antineoplastic Agents, Hormonal--administration & dosage
Breast Neoplasms--drug therapy
Cost-Benefit Analysis
Female
Humans
Letrozole
Markov Chains
Neoplasm Recurrence, Local
Neoplasms, Hormone-Dependent--drug therapy
Nitriles--administration & dosage
Postmenopause
Quality of Life
Randomized Controlled Trials as Topic
Tamoxifen--administration & dosage
Triazoles--administration & dosage
United Kingdom--epidemiology
Cost utility analysis of early adjuvant letrozole or anastrozole versus tamoxifen in postmenopausal women with early invasive breast cancer: the UK perspective. [electronic resource] - The European journal of health economics : HEPAC : health economics in prevention and care May 2008 - 171-83 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1618-7598
10.1007/s10198-007-0058-1 doi
Anastrozole
Antineoplastic Agents--administration & dosage
Antineoplastic Agents, Hormonal--administration & dosage
Breast Neoplasms--drug therapy
Cost-Benefit Analysis
Female
Humans
Letrozole
Markov Chains
Neoplasm Recurrence, Local
Neoplasms, Hormone-Dependent--drug therapy
Nitriles--administration & dosage
Postmenopause
Quality of Life
Randomized Controlled Trials as Topic
Tamoxifen--administration & dosage
Triazoles--administration & dosage
United Kingdom--epidemiology